Literature DB >> 18755928

Severe pulmonary arterial hypertension: a forme fruste of cancer?

Marc Humbert, Marius M Hoeper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755928     DOI: 10.1164/rccm.200806-867ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

Authors:  Micheala A Aldred; Suzy A Comhair; Marileila Varella-Garcia; Kewal Asosingh; Weiling Xu; George P Noon; Patricia A Thistlethwaite; Rubin M Tuder; Serpil C Erzurum; Mark W Geraci; Christopher D Coldren
Journal:  Am J Respir Crit Care Med       Date:  2010-06-25       Impact factor: 21.405

2.  A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.

Authors:  M Gomberg-Maitland; M L Maitland; R J Barst; L Sugeng; S Coslet; T J Perrino; L Bond; M E Lacouture; S L Archer; M J Ratain
Journal:  Clin Pharmacol Ther       Date:  2009-12-09       Impact factor: 6.875

3.  Waiting in anticipation: the genetics of pulmonary arterial hypertension.

Authors:  Micheala A Aldred; Nicholas W Morrell
Journal:  Am J Respir Crit Care Med       Date:  2012-11-01       Impact factor: 21.405

4.  Genomic stability of pulmonary artery endothelial colony-forming cells in culture.

Authors:  Kylie M Drake; Chiara Federici; Heng T Duong; Suzy A Comhair; Serpil C Erzurum; Kewal Asosingh; Micheala A Aldred
Journal:  Pulm Circ       Date:  2017-05-12       Impact factor: 3.017

5.  Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension.

Authors:  Jamie L Wilson; Lizhen Wang; Zeyu Zhang; Nicholas S Hill; Peter Polgar
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.